s6y
Company name or ticker
Search
4D Molecular Therapeutics, Inc.
4
Kamal Fariborz: Statement of changes in beneficial ownership of securities
Filed
Tuesday, September 27, 2022
Period
Sep 23, 2022
Accession number
0001567619-22-017847
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header